β-Carotene affects cancer pathways through Pin1 inhibition and PI3K/AKT signaling suppression; however, clinical studies reveal an increased lung cancer risk in smokers (RR: 1.19; 95% CI: 1.08–1.32), emphasizing the importance of personalized approaches based on individual risk factors (48). This evidence concerns the gene AKT1 and lung cancer.